Persistent elevation of fibroblast growth factor 23 concentrations in healthy appropriate-for-gestational-age preterm infants

Journal of Pediatric Endocrinology and Metabolism

Volumn 28, Issue 7-8, 2015, Pages 825-832

  Fatani, Tarah ^b   Binjab, Asma ^b   Weiler, Hope ^c   Sharma, Atul ^d   Rodd, Celia ^a,d  

^a CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

calcium; FGF23; phosphorus; premature infant; Vitamin D

Indexed keywords

CALCIUM; COLECALCIFEROL; CREATININE; FIBROBLAST GROWTH FACTOR 23; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHORUS; ANGIOTENSINAMIDE; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR;

ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GESTATIONAL AGE; HEMOGLOBIN DETERMINATION; HUMAN; INFANT; LIQUID CHROMATOGRAPHY; MALE; PREMATURITY; PROSPECTIVE STUDY; TANDEM MASS SPECTROMETRY; ADULT; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; FOLLOW UP; NEWBORN; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PROGNOSIS; TERM BIRTH;

ADULT; ANGIOTENSIN AMIDE; BIOMARKERS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; DIABETES, GESTATIONAL; FEMALE; FIBROBLAST GROWTH FACTORS; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PRE-ECLAMPSIA; PREGNANCY; PROGNOSIS; PROSPECTIVE STUDIES; TANDEM MASS SPECTROMETRY; TERM BIRTH;

EID: 84937878205     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2014-0186     Document Type: Article

References (37)

1. Bishop N, Sprigg A, Dalton A. Unexplained fractures in infancy: looking for fragile bones. Arch Dis Childhood 2007;92:251-6.
2. Bozzetti V, Tagliabue P. Metabolic bone disease in preterm newborn: an update on nutritional issues. Italian J Pediatr 2009;35:20.
3. Beyers N, Alheit B, Taljaard JF, Hall JM, Hough SF. High turnover osteopenia in preterm babies. Bone 1994;15:5-13.
4. Lucas-Herald A, Butler S, Mactier H, McDevitt H, Young D, et al. Prevalence and characteristics of rib fractures in ex-preterm infants. Pediatrics 2012;130:1116-9.
5. Viswanathan S, Khasawneh W, McNelis K, Dykstra C, Amstadt R, et al. Metabolic bone disease: a continued challenge in extremely low birth weight infants. J Parenteral Enteral Nutr 2014;38:982-90.
6. Moyer-Mileur LJ, Brunstetter V, McNaught TP, Gill G, Chan GM. Daily physical activity program increases bone mineralization and growth in preterm very low birth weight infants. Pediatrics 2000;106:1088-92.
7. Gallo S, Comeau K, Vanstone C, Agellon S, Sharma A, et al. Effect of different dosages of oral vitamin D supplementation on vitamin D status in healthy, breastfed infants: a randomized trial. J Am Med Assoc 2013;309:1785-92.
8. Singh RJ, Taylor RL, Reddy GS, Grebe SK. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metabol 2006;91:3055-61.
9. Lensmeyer G, Poquette M, Wiebe D, Binkley N. The C-3 epimer of 25-hydroxyvitamin D(3) is present in adult serum. J Clin Endocrinol Metabol 2012;97:163-8.
10. Shah I, James R, Barker J, Petroczi A, Naughton DP. Misleading measures in Vitamin D analysis: a novel LC-MS/MS assay to account for epimers and isobars. Nutr J 2011;10:46.
11. Takaiwa M, Aya K, Miyai T, Hasegawa K, Yokoyama M, et al. Fibroblast growth factor 23 concentrations in healthy term infants during the early postpartum period. Bone 2010;47:256-62.
12. Dawodu A, Tsang RC. Maternal vitamin D status: effect on milk vitamin D content and vitamin D status of breastfeeding infants. Adv Nutr (Bethesda, MD). 2012;3:353-61.
13. Carter GD, Berry JL, Gunter E, Jones G, Jones JC, et al. Proficiency testing of 25-hydroxyvitamin D (25-OHD) assays. J Steroid Biochem Mol Biol 2010;121:176-9.
14. Carter GD, Carter CR, Gunter E, Jones J, Jones G, et al. Measurement of Vitamin D metabolites: an international perspective on methodology and clinical interpretation. J Steroid Biochem Mol Biol 2004;89-90:467-71.
15. Fenton TR. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr 2003;3:13.
16. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin N Am 1987;34:571-90.
17. Vieux R, Hascoet JM, Merdariu D, Fresson J, Guillemin F. Glomerular filtration rate reference values in very preterm infants. Pediatrics 2010;125:e1186-92.
18. Team RC. A language and environment for statistical computer. R Foundation for Statistical Computing, Vienna, Austria. 2013. Available at: http://www.R-project.org/.
19. Backstrom MC, Maki R, Kuusela AL, Sievanen H, Koivisto AM, et al. Randomised controlled trial of vitamin D supplementation on bone density and biochemical indices in preterm infants. Arch Dis Childhood Fetal Neonatal Edn 1999;80:F161-6.
20. McCarthy RA, McKenna MJ, Oyefeso O, Uduma O, Murray BF, et al. Vitamin D nutritional status in preterm infants and response to supplementation. Br J Nutr 2013;110:156-63.
21. Giapros VI, Schiza V, Challa AS, Cholevas VK, Theocharis PD, et al. Vitamin D and parathormone levels of late-preterm formula fed infants during the first year of life. Eur J Clin Nutr 2012;66:224-30.
22. Jopling J, Henry E, Wiedmeier SE, Christensen RD. Reference ranges for hematocrit and blood hemoglobin concentration during the neonatal period: data from a multihospital health care system. Pediatrics 2009;123:e333-7.
23. Ohls RK. Core concepts: the biology of hemoglobin. Neo Reviews 2011;12:e29-38.
24. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academy Press, 2011.
25. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-30.
26. Abrams SA. Calcium and vitamin D requirements of enterally fed preterm infants. Pediatrics 2013;131:e1676-83.
27. Braegger C, Campoy C, Colomb V, Decsi T, Domellof M, et al. Vitamin D in the healthy European paediatric population. J Pediatr Gastroenterol Nutr 2013;56:692-701.
28. Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008;122:1142-52.
29. Salle BL, Delvin EE, Lapillonne A, Bishop NJ, Glorieux FH. Perinatal metabolism of vitamin D. Am J Clin Nutr 2000;71: 1317s-24s.
30. Gallo S, Comeau K, Agellon S, Vanstone C, Sharma A, et al. Methodological issues in assessing plasma 25-hydroxyvitamin D concentration in newborn infants. Bone 2014;61:186-90.
31. Bergwitz C, Juppner, H. Regulation of phoshphate homeostasis by PTH, vitamin D and FGF23. Annu Rev Med 2010;61:91-104.
32. Isakova T, Wahl P, Vargas GS, Gutierrez OM, Scialla J, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011;79:1370-8.
33. Clinkenbeard EL, Farrow EG, Summers LJ, Cass TA, Roberts JL, et al. Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice. J Bone Miner Res 2014;29:361-9.
34. Durham BH, Joseph F, Bailey LM, Fraser WD. The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays. Ann Clin Biochem 2007;44:463-6.
35. Imel EA, Peacock M, Gray AK, Padgett LR, Hui SL, et al. Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. J Clin Endocrinol Metabol 2011;96:3541-9.
36. Bhattacharyya N, Chong WH, Gafni RI, Collins MT. Fibroblast growth factor 23: state of the field and future directions. Trends Endocrinol Metabol 2012;23:610-18.
37. Ohata Y, Arahori H, Namba N, Kitaoka T, Hirai H, et al. Circulating levels of soluble alpha-Klotho are markedly elevated in human umbilical cord blood. J Clin Endocrinol Metabol 2011;96:E943-7.